APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canagliflozin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Canagliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025177 pages

Choose your research edition.

Industry ResearchCanagliflozin Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Canagliflozin Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Canagliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canagliflozin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Canagliflozin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Canagliflozin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Canagliflozin include Hansoh Pharma, Mitsubishi Tanabe Pharma, Hinye and Janssen Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Canagliflozin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Canagliflozin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Canagliflozin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Canagliflozin market size, projected growth trends, production technologies, key applications, and end-use industries.

Canagliflozin Segment by Company

Hansoh Pharma

Mitsubishi Tanabe Pharma

Hinye

Janssen Pharmaceuticals

Canagliflozin Segment by Type

100mg

300mg

Canagliflozin Segment by Application

Diabetes

Heart Disease

Others

Canagliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canagliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canagliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canagliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Canagliflozin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Canagliflozin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Canagliflozin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Canagliflozin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Canagliflozin Industry Trends Table 2. Canagliflozin Industry Drivers Table 3. Canagliflozin Industry Opportunities and Challenges Table 4. Canagliflozin Industry Restraints Table 5. Global Canagliflozin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Canagliflozin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Canagliflozin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Canagliflozin Sales Market Share by Manufacturers Table 9. Global Canagliflozin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Canagliflozin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Canagliflozin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Canagliflozin Manufacturers, Product Type & Application Table 13. Global Canagliflozin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Canagliflozin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg Table 17. Major Manufacturers of 300mg Table 18. Global Canagliflozin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Canagliflozin Sales by Type (2021-2026) & (K Units) Table 20. Global Canagliflozin Sales by Type (2027-2032) & (K Units) Table 21. Global Canagliflozin Sales Market Share by Type (2021-2026) Table 22. Global Canagliflozin Sales Market Share by Type (2027-2032) Table 23. Global Canagliflozin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Canagliflozin Revenue by Type (2021-2026) & (K Units) Table 25. Global Canagliflozin Revenue by Type (2027-2032) & (K Units) Table 26. Global Canagliflozin Revenue Market Share by Type (2021-2026) Table 27. Global Canagliflozin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Diabetes Table 29. Major Manufacturers of Heart Disease Table 30. Major Manufacturers of Others Table 31. Global Canagliflozin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Canagliflozin Sales by Application (2021-2026) & (K Units) Table 33. Global Canagliflozin Sales by Application (2027-2032) & (K Units) Table 34. Global Canagliflozin Sales Market Share by Application (2021-2026) Table 35. Global Canagliflozin Sales Market Share by Application (2027-2032) Table 36. Global Canagliflozin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Canagliflozin Revenue by Application (2021-2026) & (K Units) Table 38. Global Canagliflozin Revenue by Application (2027-2032) & (K Units) Table 39. Global Canagliflozin Revenue Market Share by Application (2021-2026) Table 40. Global Canagliflozin Revenue Market Share by Application (2027-2032) Table 41. Global Canagliflozin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Canagliflozin Sales by Region (2021-2026) & (K Units) Table 43. Global Canagliflozin Sales Market Share by Region (2021-2026) Table 44. Global Canagliflozin Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Canagliflozin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Canagliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Canagliflozin Sales by Country (2021-2026) & (K Units) Table 48. North America Canagliflozin Sales by Country (2027-2032) & (K Units) Table 49. Europe Canagliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Canagliflozin Sales by Country (2021-2026) & (K Units) Table 51. Europe Canagliflozin Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Canagliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Canagliflozin Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Canagliflozin Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Canagliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Canagliflozin Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Canagliflozin Sales by Country (2027-2032) & (K Units) Table 58. Global Canagliflozin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Canagliflozin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Canagliflozin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Canagliflozin Revenue Market Share by Region (2021-2026) Table 62. Global Canagliflozin Revenue Market Share by Region (2027-2032) Table 63. Hansoh Pharma Company Information Table 64. Hansoh Pharma Business Overview Table 65. Hansoh Pharma Canagliflozin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Hansoh Pharma Canagliflozin Product Portfolio Table 67. Hansoh Pharma Recent Development Table 68. Mitsubishi Tanabe Pharma Company Information Table 69. Mitsubishi Tanabe Pharma Business Overview Table 70. Mitsubishi Tanabe Pharma Canagliflozin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio Table 72. Mitsubishi Tanabe Pharma Recent Development Table 73. Hinye Company Information Table 74. Hinye Business Overview Table 75. Hinye Canagliflozin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hinye Canagliflozin Product Portfolio Table 77. Hinye Recent Development Table 78. Janssen Pharmaceuticals Company Information Table 79. Janssen Pharmaceuticals Business Overview Table 80. Janssen Pharmaceuticals Canagliflozin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Janssen Pharmaceuticals Canagliflozin Product Portfolio Table 82. Janssen Pharmaceuticals Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Canagliflozin Distributors List Table 86. Canagliflozin Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Canagliflozin Product Image Figure 2. Global Canagliflozin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canagliflozin Market Size (2021-2032) & (US$ Million) Figure 4. Global Canagliflozin Sales (2021-2032) & (K Units) Figure 5. Global Canagliflozin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Canagliflozin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg Image Figure 9. 300mg Image Figure 10. Global Canagliflozin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Canagliflozin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Canagliflozin Sales Market Share by Type (2021-2032) Figure 13. Global Canagliflozin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Canagliflozin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Canagliflozin Revenue Market Share by Type (2021-2032) Figure 16. Diabetes Image Figure 17. Heart Disease Image Figure 18. Others Image Figure 19. Global Canagliflozin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Canagliflozin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Canagliflozin Sales Market Share by Application (2021-2032) Figure 22. Global Canagliflozin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Canagliflozin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Canagliflozin Revenue Market Share by Application (2021-2032) Figure 25. North America Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Canagliflozin Sales Market Share by Country (2021-2032) Figure 27. U.S. Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Canagliflozin Sales Market Share by Country (2021-2032) Figure 32. Germany Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Canagliflozin Sales Market Share by Country (2021-2032) Figure 39. China Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Canagliflozin Sales Market Share by Country (2021-2032) Figure 47. Brazil Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Canagliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Canagliflozin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Canagliflozin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Canagliflozin Revenue (2021-2032) & (US$ Million) Figure 58. North America Canagliflozin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Canagliflozin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Canagliflozin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Canagliflozin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Canagliflozin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Canagliflozin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Canagliflozin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Canagliflozin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Canagliflozin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 300mg
Applications
  • Diabetes
  • Heart Disease
  • Others
Companies covered
  • Hansoh Pharma
  • Mitsubishi Tanabe Pharma
  • Hinye
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Canagliflozin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Canagliflozin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Canagliflozin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Canagliflozin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Canagliflozin Market Dynamics
  1. 2.1 Canagliflozin Industry Trends
  2. 2.2 Canagliflozin Industry Drivers
  3. 2.3 Canagliflozin Industry Opportunities and Challenges
  4. 2.4 Canagliflozin Industry Restraints
3 Canagliflozin Market by Manufacturers
  1. 3.1 Global Canagliflozin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Canagliflozin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Canagliflozin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Canagliflozin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Canagliflozin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Canagliflozin Manufacturers, Product Type & Application
  7. 3.7 Global Canagliflozin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Canagliflozin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Canagliflozin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Canagliflozin Tier 1, Tier 2, and Tier 3
4 Canagliflozin Market by Type
  1. 4.1 Canagliflozin Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 300mg
  4. 4.2 Global Canagliflozin Sales by Type
  5. 4.2.1 Global Canagliflozin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Canagliflozin Sales by Type (2021-2032)
  7. 4.2.3 Global Canagliflozin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Canagliflozin Revenue by Type
  9. 4.3.1 Global Canagliflozin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Canagliflozin Revenue by Type (2021-2032)
  11. 4.3.3 Global Canagliflozin Revenue Market Share by Type (2021-2032)
5 Canagliflozin Market by Application
  1. 5.1 Canagliflozin Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Heart Disease
  4. 5.1.3 Others
  5. 5.2 Global Canagliflozin Sales by Application
  6. 5.2.1 Global Canagliflozin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Canagliflozin Sales by Application (2021-2032)
  8. 5.2.3 Global Canagliflozin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Canagliflozin Revenue by Application
  10. 5.3.1 Global Canagliflozin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Canagliflozin Revenue by Application (2021-2032)
  12. 5.3.3 Global Canagliflozin Revenue Market Share by Application (2021-2032)
6 Global Canagliflozin Sales by Region
  1. 6.1 Global Canagliflozin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Canagliflozin Sales by Region (2021-2032)
  3. 6.2.1 Global Canagliflozin Sales by Region (2021-2026)
  4. 6.2.2 Global Canagliflozin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Canagliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Canagliflozin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Canagliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Canagliflozin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Canagliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Canagliflozin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Canagliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Canagliflozin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Canagliflozin Revenue by Region
  1. 7.1 Global Canagliflozin Revenue by Region
  2. 7.1.1 Global Canagliflozin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Canagliflozin Revenue by Region (2021-2026)
  4. 7.1.3 Global Canagliflozin Revenue by Region (2027-2032)
  5. 7.1.4 Global Canagliflozin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Canagliflozin Revenue (2021-2032)
  8. 7.2.2 North America Canagliflozin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Canagliflozin Revenue (2021-2032)
  11. 7.3.2 Europe Canagliflozin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Canagliflozin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Canagliflozin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Canagliflozin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Canagliflozin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Hansoh Pharma
  2. 8.1.1 Hansoh Pharma Company Information
  3. 8.1.2 Hansoh Pharma Business Overview
  4. 8.1.3 Hansoh Pharma Canagliflozin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hansoh Pharma Canagliflozin Product Portfolio
  6. 8.1.5 Hansoh Pharma Recent Developments
  7. 8.2 Mitsubishi Tanabe Pharma
  8. 8.2.1 Mitsubishi Tanabe Pharma Company Information
  9. 8.2.2 Mitsubishi Tanabe Pharma Business Overview
  10. 8.2.3 Mitsubishi Tanabe Pharma Canagliflozin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio
  12. 8.2.5 Mitsubishi Tanabe Pharma Recent Developments
  13. 8.3 Hinye
  14. 8.3.1 Hinye Company Information
  15. 8.3.2 Hinye Business Overview
  16. 8.3.3 Hinye Canagliflozin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hinye Canagliflozin Product Portfolio
  18. 8.3.5 Hinye Recent Developments
  19. 8.4 Janssen Pharmaceuticals
  20. 8.4.1 Janssen Pharmaceuticals Company Information
  21. 8.4.2 Janssen Pharmaceuticals Business Overview
  22. 8.4.3 Janssen Pharmaceuticals Canagliflozin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Janssen Pharmaceuticals Canagliflozin Product Portfolio
  24. 8.4.5 Janssen Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Canagliflozin Value Chain Analysis
  2. 9.1.1 Canagliflozin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Canagliflozin Production Mode & Process
  6. 9.2 Canagliflozin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Canagliflozin Distributors
  9. 9.2.3 Canagliflozin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst